Daewoong Links With Vital Brazil On Biologics
This article was originally published in PharmAsia News
Executive Summary
South Korea's Daewoong Pharm is seeking to advance into Brazil, one of the biggest and most rapidly growing pharma markets in Latin America, by signing a memorandum of understanding with the country's state-run pharma lab Instituto Vital Brazil for cooperation in biologics technology.